Harnessing Liquid Biopsy to Optimize Antibody-Drug Conjugate Development & Treatment Strategies
Time: 9:00 am
day: Conference Day 2
Details:
- How can liquid biopsy improve patient selection and biomarker-driven stratification for ADC therapies?
- What role can ctDNA and other circulating biomarkers play in monitoring ADC efficacy and resistance mechanisms?
- How can liquid biopsy help refine ADC dosing strategies by providing real-time pharmacodynamic insights?
Anti-Body Drug Conjugates
